Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESTRO 2022 | Highlights in breast and gynecological cancer at ESTRO 2022

Pedro Lara • 17 May 2022
ESTRO 2022
Breast Cancer Gynecological Cancer

Pedro Lara, MD, PhD, Fernando Pessoa Canarias University and San Roque University Hospital, Gran Canarias, Spain, discusses what he thought were two key presentations at ESTRO 2022 in breast and gynecological cancers. This interview took place at the European Society for Radiotherapy and Oncology (ESTRO) 2022 annual congress in Copenhagen, Denmark, and online.

More from Pedro Lara

1:43
How can we optimise the use of patient reported outcomes in clinical practice?
Pedro Lara • 16 May 2022
1:17
The importance of Patient Reported Outcomes in clinical trials
Pedro Lara • 16 May 2022

Related Videos

0:39
Early diagnosis of ovarian cancer with Pap smears
Sergio Marchini • 8 Apr 2024
0:46
FRa expression and sequencing ADCs in endometrial cancer
Rebecca Porter • 8 Apr 2024
4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals